Showing 1 - 20 results of 18,729 for search '(( 5 nm decrease ) OR ((( _ point decrease ) OR ( _ ((nn decrease) OR (fold decrease)) ))))', query time: 0.39s Refine Results
  1. 1

    Genes whose expression was decreased by 100 nM ouabain by more than 1.3-fold. by Larisa V. Smolyaninova (3600053)

    Published 2019
    “…<p>Genes whose expression was decreased by 100 nM ouabain by more than 1.3-fold.</p>…”
  2. 2

    Genes whose expression was decreased by 1 mM ouabain by more than 2-fold. by Larisa V. Smolyaninova (3600053)

    Published 2019
    “…<p>Genes whose expression was decreased by 1 mM ouabain by more than 2-fold.</p>…”
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. by Djaloul Karboua (16510091)

    Published 2023
    “…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.</p>…”
  8. 8
  9. 9
  10. 10
  11. 11

    Point elasticity of demand decreasing price by Rod Shaw (1258020)

    Published 2020
    “…Point elasticity of demand decreasing price…”
  12. 12
  13. 13
  14. 14

    TUDCA decreases ER stress in HOX neonatal rat lungs. by Kirkwood A. Pritchard Jr. (13449794)

    Published 2022
    “…<p>(<b>A</b>) The expression levels of ER stress markers (P-PERK 0.6±0.1-fold, p<0.001, n = 5; PERK 0.7±0.1-fold, p = 0.00364, n = 5; P-IRE1α 0.6±0.0-fold, p<0.001, n = 5; IRE1α 0.6±0.1-fold, p<0.001, n = 5; GRP78 0.8±0.1-fold, p<0.001, n = 5; cleaved ATF6 0.1±0.0-fold, p<0.001, n = 5; spliced XBP1 0.3±0.0-fold, p<0.001, n = 5; 2 males and 3 females) are all decreased while the N-glycosylated VEGFR2 is increased (3.5±0.2-fold, p<0.001, n = 5) in HOX neonatal lungs at P10 indicating TUDCA can attenuate hyperoxia-induced ER stress. …”
  15. 15
  16. 16
  17. 17
  18. 18

    Averages of the fold decreases in the MICs of tested antibiotics in the presence of the tested compounds. by Safaa Abdel-Aal Mohamed Abdel-Karim (13175696)

    Published 2022
    “…<p>Averages of the fold decreases in the MICs of tested antibiotics in the presence of the tested compounds.…”
  19. 19
  20. 20